Life Sciences

40+ years representing leading global life sciences companies


  • Corporate
  • Litigation
  • Regulatory
  • Intellectual Property

  • Band 1 for US Nationwide and California Life Sciences — Chambers

  • Tier 1 for Healthcare: Life Sciences in 2021 — Legal 500 US 

  • Consistently rank #1 for global biotech & pharma licensing — BioPharm Insight

  • #1 in issuer-side life sciences IPOs since 2000

  • #1 for biotech and pharma venture financings for the last decade, including in 2018 — PitchBook

  • #2 M&A law firm for biotech and pharma M&A transactions in 2018, 2019 & Q3 2020

  • "Highly Recommended” law firm for general corporate, licensing & collaborations, and M&A in 2019 — LMG Life Sciences

  • Dedicated, international practice group of 40+ professionals across the US, Europe and China exclusively focused on corporate partnering, licensing, M&A and other commercial transactions specific to life sciences companies

Read more

  • Defended more life sciences companies in shareholder litigation filed over the past ten years than any other firm

  • Achieved groundbreaking victories on behalf of life sciences clients in the US Supreme Court and California Supreme Court

  • Complete wins in commercially significant drug ownership and licensing disputes 

  •  Decades of experience litigating Hatch-Waxman matters for branded pharmaceutical companies

  •  Defend False Claims Act actions arising from allegations of billing/coding misconduct, patient safety and research misconduct, manufacturing deficiencies, other Food, Drug and Cosmetic Act  violations, drug pricing misconduct, federal and state anti-kickback law violations, and other relevant fraud and abuse laws led by local, state and federal civil and criminal government enforcers

  • Experience in more than 100+ state, federal and international courts, arbitral forums and administrative bodies

  • Team includes 5 Fellows of the American College of Trial Lawyers and 20+ former Assistant US Attorneys and Department of Justice lawyers

  • Ranked #4 Most Innovative Law Firm by the Financial Times – recognized for Protecting Clients Business for litigating on behalf of our clients 

Read more

  • Deep US and global experience providing regulatory counseling and advice on FDA, fraud & abuse, corporate compliance, contractual relationships, Sunshine Laws, reimbursement, government program price reporting, healthcare data privacy, licensure and accreditation, health reform counseling, regulatory due diligences, MHRA and CE Marking 

  • Advise all players in the evolving ecosystem, including payors, providers, LS companies, health IT and investors

  • As connectors to the ecosystem, we counsel clients on how to launch innovative products and services

  • Represent healthcare clients in connection with federal and state government investigations, inquiries, settlements and voluntary disclosures, leveraging subject matter expertise and litigation and negotiation experience

  • Counsel related to privacy and data protection, government contracts and government analytics practices provided by multidisciplinary team bolstered by industry-leading lawyers

  • Frequent contributors on groundbreaking regulatory topics at leading industry events, editorial boards and relevant media and publications

  • Market leader in life sciences — #1 in IPOs, M&A transactions, venture financings and licensing

Read more

  • 90+ person life sciences patent team across the US and UK (90% hold PhDs)

  • The largest life sciences patent practice in the US

  • 31,000+ Patents currently under our management worldwide

  • 1,000+ IP due diligence reviews in life sciences deals/transactions

  • One of the most active IP litigation practices in the US with 500+ cases in the last 5 years

  • Complete wins in commercially significant drug ownership and licensing disputes

  • Decades of experience litigating Hatch-Waxman matters for branded pharmaceutical companies 

  • Specialized branding team provides guidance on selecting, clearing, protecting and obtaining regulatory approval for drug and device names

  • "Patent Strategy and Management Firm of the Year" Honoree – LMG Life Sciences (2018)

Read more

According to industry peers, the licensing, tax and inversion, private investment, capital market and M&A work performed by Cooley is top tier. - LMG Life Sciences

Cooley’s Life Sciences + Healthcare Innovation Program

Read more

Life Sciences & Healthcare Innovation Hub

Comprehensive resource for key stakeholders across the global life sciences and healthcare industry

Visit hub

Group Contacts
Kay Chandler Partner San Diego
Christian Plaza Partner Reston, Boston
Orion Armon Partner Colorado
Laura Berezin Partner Palo Alto
Barbara Borden Partner San Diego
Tom Coll Partner San Diego
Jonathan Davies Partner Washington, DC
Ivor Elrifi Partner New York, Boston
Sonya Erickson Partner Seattle
Lester Fagen Senior Counsel Boston
Brent Fassett Partner Colorado
Wainwright Fishburn Senior Counsel San Diego
Eamonn Gardner Partner Colorado
Jon Graves Senior Counsel Reston
Robert L. Jones Partner Palo Alto
Daniel Knauss Partner Palo Alto
Kenneth Krisko Partner Reston, Boston
Nicola Maguire Partner London
Mika Reiner Mayer Partner Palo Alto
Erik Milch Partner Reston
Chadwick Mills Partner San Francisco
Adam Pivovar Partner Washington, DC
Marya Postner Partner Palo Alto
Marc Recht Partner Boston
Michelle Rhyu Partner Palo Alto
Sanya Sukduang Partner Washington, DC
Michael Tuscan Partner in Charge – Washington, DC Washington, DC
John Wilkinson Partner London
Christina Zhang Partner in Charge – Shanghai Shanghai
ViewHide related contacts


Listing Returned 0 Results.

ViewHide related news


Listing Returned 0 Results.

ViewHide related events


Listing Returned 0 Results.